低传播地区反应性靶向室内滞留喷洒的效果与成本效果:南非整群随机非劣效试验
该整群随机开放标签非劣效试验在南非东北部两个疟疾季节比较反应性靶向IRS与标准IRS。靶向IRS仅喷洒指示病例住址及紧邻住户。
要点
- 在94-98%概率下靶向IRS相对于南非阈值(每避免一个DALY 2637至3557美元)具有成本效果。
核心结论
- 在极低传播环境中,反应性靶向IRS与标准IRS相比为非劣效、安全、成本更低且具有成本效果。
- 节省的资源可重新分配至其他疟疾控制和消除活动。
研究设计与样本
- 整群随机、开放标签、非劣效试验,在南非东北部两个疟疾季节(2015-17)比较反应性靶向IRS与标准IRS。
- 标准IRS组由项目管理者基于历史数据、专家意见等因素优先区域开展年度大规模喷洒;靶向IRS组仅喷洒被动监测发现的指示病例住址及紧邻住户。
- 非劣效界值为每1000人年1例;基于原始和二次数据建模实际实施中的卫生服务成本,估算每DALY增量成本并进行确定性和概率敏感性分析。
- 试验注册号ClinicalTrials.gov NCT02556242。
主要发现
- 转为靶向IRS具有成本效果的概率为94-98%,相对于南非合理成本效果阈值(每避免一个DALY 2637至3557美元)。
关键数值与推荐
- 非劣效界值:每1000人年1例。
- 南非成本效果阈值:每避免一个DALY 2637至3557美元;靶向IRS具有成本效果的概率94-98%。
临床怎么用
- 在极低传播环境中,可考虑采用反应性靶向IRS替代标准IRS以降低成本和维持疟疾控制效果。
- 靶向策略仅喷洒指示病例住址及紧邻住户,需依赖被动监测系统及时识别指示病例。
- 节省的资源可用于其他疟疾控制和消除活动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increasing insecticide costs and constrained malaria budgets could make universal vector control strategies, such as indoor residual spraying (IRS), unsustainable in low-transmission settings. We investigated the effectiveness and cost-effectiveness of a reactive, targeted IRS strategy. METHODS: This cluster-randomised, open-label, non-inferiority trial compared reactive, targeted IRS with standard IRS practice in northeastern South Africa over two malaria seasons (2015-17). In standard IRS clusters, programme managers conducted annual mass spray campaigns prioritising areas using historical data, expert opinion, and other factors. In targeted IRS clusters, only houses of index cases (identified through passive surveillance) and their immediate neighbours were sprayed. The non-inferiority margin was 1 case per 1000 person-years. Health service costs of real-world implementation were modelled from primary and secondary data. Incremental costs per disability-adjusted life-year (DALY) were estimated and deterministic and probabilistic sensitivity analyses conducted. This study is registered with ClinicalTrials.gov, NCT02556242. FINDINGS: Malaria incidence was 0·95 per 1000 person-years (95% CI 0·58 to 1·32) in the standard IRS group and 1·05 per 1000 person-years (0·72 to 1·38) in the targeted IRS group, corresponding to a rate difference of 0·10 per 1000 person-years (-0·38 to 0·59), demonstrating non-inferiority for targeted IRS (p<0·0001). Per additional DALY incurred, targeted IRS saved US$7845 (2902 to 64 907), giving a 94-98% probability that switching to targeted IRS would be cost-effective relative to plausible cost-effectiveness thresholds for South Africa ($2637 to $3557 per DALY averted). Depending on the threshold used, targeted IRS would remain cost-effective at incidences of less than 2·0-2·7 per 1000 person-years. Findings were robust to plausible variation in other parameters. INTERPRETATION: Targeted IRS was non-inferior, safe, less costly, and cost-effective compared with standard IRS in this very-low-transmission setting. Saved resources could be reallocated to other malaria control and elimination activities. FUNDING: Joint Global Health Trials.
引用
- Bath D, Cook J, Govere J, et al. Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa. Lancet. 2021. PMID: 33640068. doi:10.1016/S0140-6736(21)00251-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。